258 related articles for article (PubMed ID: 17713753)
1. [Nephrogenic systemic fibrosis as an adverse drug reaction of gadolinium-based contrast media for magnetic resonance imaging].
Giersig C
Radiologe; 2007 Sep; 47(9):794-9. PubMed ID: 17713753
[TBL] [Abstract][Full Text] [Related]
2. [Nephrogenic systemic fibrosis--a new interdisciplinary challenge].
Witzke O; Hillen U; Barkhausen J; Daul A; Kribben A
Dtsch Med Wochenschr; 2007 Dec; 132(50):2706-10. PubMed ID: 18058663
[TBL] [Abstract][Full Text] [Related]
3. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
[TBL] [Abstract][Full Text] [Related]
4. [Nephrogenic systemic fibrosis].
Samtleben W
Radiologe; 2007 Sep; 47(9):778-84. PubMed ID: 17717643
[TBL] [Abstract][Full Text] [Related]
5. Influence of excess ligand on Nephrogenic Systemic Fibrosis associated with nonionic, linear gadolinium-based contrast agents.
Semelka RC; Prybylski JP; Ramalho M
Magn Reson Imaging; 2019 May; 58():174-178. PubMed ID: 30471330
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
Wiginton CD; Kelly B; Oto A; Jesse M; Aristimuno P; Ernst R; Chaljub G
AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
[TBL] [Abstract][Full Text] [Related]
7. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
Prasad SR; Jagirdar J
J Comput Assist Tomogr; 2008; 32(1):1-3. PubMed ID: 18303280
[TBL] [Abstract][Full Text] [Related]
8. [Nephrogenic systemic fibrosis (NSF)--implications for radiology].
Michaely HJ; Thomsen HS; Reiser MF; Schoenberg SO
Radiologe; 2007 Sep; 47(9):785-93. PubMed ID: 17624507
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
Bennett LK; Garrett AL
Cutis; 2008 May; 81(5):421-6. PubMed ID: 18543594
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
Stratta P; Canavese C; Aime S
Curr Med Chem; 2008; 15(12):1229-35. PubMed ID: 18473815
[TBL] [Abstract][Full Text] [Related]
11. Nephrogenic systemic fibrosis: risk factors and incidence estimation.
Sadowski EA; Bennett LK; Chan MR; Wentland AL; Garrett AL; Garrett RW; Djamali A
Radiology; 2007 Apr; 243(1):148-57. PubMed ID: 17267695
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Broome DR
Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
[TBL] [Abstract][Full Text] [Related]
13. Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
Bongartz G
MAGMA; 2007 Apr; 20(2):57-62. PubMed ID: 17436028
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium and nephrogenic systemic fibrosis: association or causation.
Kurtkoti J; Snow T; Hiremagalur B
Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.
Moreno-Romero JA; Segura S; Mascaró JM; Cowper SE; Julià M; Poch E; Botey A; Herrero C
Br J Dermatol; 2007 Oct; 157(4):783-7. PubMed ID: 17627792
[TBL] [Abstract][Full Text] [Related]
16. Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis?
Saab G; Abu-Alfa A
Radiology; 2007 Sep; 244(3):930-1; author reply 931-2. PubMed ID: 17709844
[No Abstract] [Full Text] [Related]
17. [Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
van der Meij N; Keur I; van Lienden KP; Scheepstra CG; Bos JD
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2898-903. PubMed ID: 18257437
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic systemic fibrosis: possible association with a predisposing infection.
Golding LP; Provenzale JM
AJR Am J Roentgenol; 2008 Apr; 190(4):1069-75. PubMed ID: 18356457
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium.
Cowper SE
Adv Dermatol; 2007; 23():131-54. PubMed ID: 18159899
[TBL] [Abstract][Full Text] [Related]
20. Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis.
Reilly RF
Clin J Am Soc Nephrol; 2008 May; 3(3):747-51. PubMed ID: 18287249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
